Page One
Berkeley scientist off to head start-up
Corey Goodman, a leading neuroscientist at the University of California, Berkeley, announced Tuesday he is leaving academia for the private sector.
Goodman, 50, will take a two-year sabbatical from the university to serve as chief executive of biotech start-up Renovis Inc. of South San Francisco.
The company, launched last year with $16.4 million in venture funding, hopes to develop drugs aimed at brain diseases. Goodman starts Sept. 1.
His exit comes on the heels of several other academic defections to private industry.
Richard Scheller left Stanford University earlier this year to become chief scientific officer at South San Francisco based-Genentech.
Last year, Peter Kim left the Massachusetts Institute of Technology for the pharmaceutical firm Merck & Co., of Whitehouse Station, N.J., where he serves as executive vice president of research and development.
